| Serial Number | 79185414 |
| Word Mark | NEMAURA |
| Filing Date | Thursday, December 24, 2015 |
| Status | 707 - PARTIAL SECTION 71 ACCEPTED |
| Status Date | Thursday, May 23, 2024 |
| Registration Number | 5293350 |
| Registration Date | Tuesday, September 26, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 11, 2017 |
| Goods and Services | [ Pharmaceutical and veterinary preparations for treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Sanitary preparations for medical purposes; Diagnostic preparations and substances for medical or veterinary purposes; Medical diagnostic reagents; Antiserums for medical or veterinary diagnostic purposes; Vaccines for human beings and animals; Adjuvants for use with vaccines; Biological laboratory preparations for medical and veterinary purposes for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Chemical preparations and reagents for medical, pharmaceutical and veterinary purposes for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Viruses for the treatment of humans and animals for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Diagnostic preparations for medical purposes; In-vitro diagnostics for medical purposes; In-vivo diagnostics for medical purposes; Medical plasters; Transdermal patches for use in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Transdermal plasters for use in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Transdermal therapeutic drug delivery systems (TTS), namely, transdermal patches and plasters treated or impregnated with pharmaceutical active ingredients for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Medicated transdermal drug delivery patches featuring medication for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Vaccines; Drug delivery agents in the form of dissolvable films, coatings for tablets, capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for injection in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalants, nasal sprays, orally disintegrating tablets, and mouthwashes that facilitate the delivery of pharmaceutical preparations; Balms for medical purposes; Tonics for medical purposes, namely, for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Disinfectants, antiseptics ] |
| Goods and Services | [ Surgical apparatus and instruments for medical, dental or veterinary use; Suture materials; Inhalers for medical purposes; Filters for inhalers for medical purposes; Inhalers for medical use; Inhalers for therapeutic use; Electromagnetic drug delivery apparatus for medical use; Drug delivery apparatus and devices, namely, medical apparatus and units for dosage, measuring and monitoring; Microneedle arrays for delivering medications; Hypodermic syringes for injections for medical purposes; Electrical drug delivery apparatus for medical use; Needles for medical and surgical use; Hypodermic needles ] |
| Goods and Services | Medical research services; Conducting clinical trials for others; Medical research laboratory services; Medical research laboratory services for the analysis of samples taken from patients; Scientific analysis and research services, namely, DNA analysis services for scientific research purposes; Product development relating to pharmaceuticals, medicines, medicaments and veterinary products; Medical and health care testing services for research purposes, namely, clinical testing services, physician testing services for assisting pharmacists, pharmaceutical testing services, and medical laboratory and testing services; Pharmaceutical research and development services; Medical and scientific research information in the field of healthcare; Cosmetics research; Design and development of computer hardware and software and information storage retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 1, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nemaura Pharma Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Leicestershire LE11 3Q GB |
| Party Name | Nemaura Pharma Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Nemaura Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Monday, April 11, 2016 | ASSIGNED TO EXAMINER |
| Thursday, March 31, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, April 1, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 5, 2016 | APPLICATION FILING RECEIPT MAILED |
| Thursday, April 21, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, April 22, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, April 22, 2016 | REFUSAL PROCESSED BY MPU |
| Friday, April 22, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, May 14, 2016 | REFUSAL PROCESSED BY IB |
| Friday, October 21, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 21, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 21, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 14, 2016 | FINAL REFUSAL WRITTEN |
| Monday, November 14, 2016 | FINAL REFUSAL E-MAILED |
| Monday, November 14, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, February 2, 2017 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, May 15, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, May 15, 2017 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, May 15, 2017 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, May 15, 2017 | EX PARTE APPEAL-INSTITUTED |
| Wednesday, May 31, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 31, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 31, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 31, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 31, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 31, 2017 | EXPARTE APPEAL TERMINATED |
| Wednesday, June 21, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 11, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 21, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 21, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, July 8, 2017 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 11, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 30, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, August 30, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, September 15, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, September 26, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Friday, December 1, 2017 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, December 26, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, January 12, 2018 | FINAL DISPOSITION PROCESSED |
| Friday, January 12, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, February 10, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, September 26, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Tuesday, September 26, 2023 | TEAS SECTION 71 RECEIVED |
| Monday, May 20, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, May 23, 2024 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Thursday, May 23, 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |